Dean Capital Management’s Medifast MED Stock Holding History

Dean Capital Management’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-12,046	Closed	-$1.11M	–	129
2023 Q2	$1.11M	Buy	12,046 +1,105	+10%	+$98.4K	1.48%	32
2023 Q1	$1.13M	Buy	10,941 +7,924	+263%	+$878K	1.48%	33
2022 Q4	$348K	Buy	+3,017	New	+$351K	0.46%	61
2017 Q3	–	Sell	-66,350	Closed	-$2.75M	–	72
2017 Q2	$2.75M	Buy	66,350 +18,995	+40%	+$826K	1.32%	40
2017 Q1	$2.1M	Buy	47,355 +5,895	+14%	+$254K	1.44%	38
2016 Q4	$1.73M	Buy	41,460 +6,175	+18%	+$249K	1.37%	40
2016 Q3	$1.33M	Buy	35,285 +32,550	+1,190%	+$1.17M	1.38%	39
2016 Q2	$91K	Buy	+2,735	New	+$88.3K	0.12%	61

Other funds holding MED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dean Capital Management's MED Position: Q3 2023 in Review

Dean Capital Management sold out of Medifast (MED) in Q3 2023, closing a stake of 12,046 shares — an estimated $1.11M sold.

Dean Capital Management first reported a position in MED in Q2 2016 and held it in 8 quarters. The position peaked at $2.75M in Q2 2017. 223 funds tracked by Wall St. Rank hold MED as of Q3 2023.

Dean Capital Management reported no remaining Medifast position as of Q3 2023 after selling out during the quarter.
Dean Capital Management sold 12,046 Medifast shares in Q3 2023, an estimated $1.11M.
Dean Capital Management first reported a position in Medifast in Q2 2016 and held it in 8 quarters.
Dean Capital Management's Medifast position peaked at $2.75M in Q2 2017.
223 funds tracked by Wall St. Rank held Medifast as of Q3 2023.

Based on Dean Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.